Ahead of print

If you wish to receive notifications about publication of new articles, click here to register as reader

Table of Contents

open access

The rehabilitation of cancer patients and the role of nurses: a scoping review


Catarina Rodrigues, Bárbara Gomes, Carlos Albuquerque

Review paper

DOI: 10.5603/OCP.2022.0018

Different MET gene alterations in lung adenocarcinoma patients


Paulina Terlecka, Paweł Krawczyk, Kamila Wojas-Krawczyk, Anna Grenda, Izabela Chmielewska, Robert Kieszko, Artur Bartczak, Janusz Milanowski

Research paper

DOI: 10.5603/OCP.2022.0019

Supportive activities in oncological wards during the COVID-19 pandemic: a qualitative study


Mahdieh Poodineh Moghadam, Ahmad Nasiri, Gholamhossein Mahmoudirad

Research paper

DOI: 10.5603/OCP.2022.0017

Benefits of β-blockers in cancer treatment


Mohamad Arif, Mardiah Suci Hardianti, Nurina Tyagita, Azizah Hikma Safitri

Review paper

DOI: 10.5603/OCP.2022.0016

Stevens-Johnson syndrome in breast cancer patient treated with ribociclib


Adam Kowalczyk, Barbara Radecka

Case report

DOI: 10.5603/OCP.2022.0004

Evolution of prostate cancer therapy. Part 1


Paweł M. Potocki, Piotr J. Wysocki

Review paper

DOI: 10.5603/OCP.2021.0001

Immunotherapy with pembrolizumab in a patient with advanced non-small-cell lung cancer with high PD-L1 expression and MET exon 14 splice site mutation: a case report


Paulina Terlecka, Paweł Krawczyk, Anna Grenda, Izabela Chmielewska, Janusz Milanowski

Case report

DOI: 10.5603/OCP.2022.0007

Microwave ablation of colorectal cancer lung metastases — the first experience in Poland


Grzegorz Rosiak, Maciej Krzakowski, Krzysztof Milczarek, Dariusz Konecki, Olgierd Rowiński

Research paper

DOI: 10.5603/OCP.2022.0008

Commentary to Targeted therapy for advanced cutaneous melanoma

Piotr Rutkowski, Katarzyna Kozak


DOI: 10.5603/OCP.2022.0010

Targeted therapy for advanced cutaneous melanoma


Alice Indini, Fausto Roila, Rossana Gueli, Francesco Grossi, Mario Mandalà

Review paper

DOI: 10.5603/OCP.2022.0005

Evaluation of the effectiveness and tolerability of sunitinib and pazopanib in the first line treatment of metastatic renal cell carcinoma


Senar Ebinç, Ziya Kalkan, Zeynep Oruç, Zuhat Urakçı, Mehmet Küçüköner, Muhammet Ali Kaplan, Abdurrahman Işıkdoğan

Research paper

DOI: 10.5603/OCP.2021.0033

Dual impact from coincide potential complications of cancer therapy and sarcopenia: a narrative review


Anmar Al-Taie, Aygül Koseoğlu

Review paper

DOI: 10.5603/OCP.2021.0023


Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl